Telomir Pharmaceuticals, Inc. TELO
1.23
0.02
1.65%
as of 25 Sep
- Market cap
- $83.2M
- P/E
- 0.0×
Follow TELO
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(301.57%) | (317.65%) | (384.26%) | (1,885.50%) | |
| (265.05%) | (240.34%) | (293.73%) | (1,678.31%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(160.34%) | (176.09%) | (185.89%) | (1,032.88%) | |
Free Cash Flow per Share |
(0.10) | (0.12) | (0.13) | (0.08) | |
Free Cash Flow |
(3.09) | (3.69) | (4.60) | (4.91) | |
Piotroski F-Score |
3.00 | 3.00 | 3.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
(21.61%) | (27.94%) | (42.87%) | (47.53%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.28 | 0.35 | 0.50 | 0.09 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.10) | (0.12) | (0.13) | (0.08) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates